Works matching DE "RIVAROXABAN"

Results: 1553

Outcomes of 10 mg Rivaroxaban in Nonvalvular Atrial Fibrillation Patients With CrCl ≥ 50 mL/min: A Retrospective Cohort Study.

Published in:

Cardiovascular Therapeutics, 2025, v. 2025, p. 1, doi. 10.1155/cdr/7021330

By:

Yan, Qing;
Yuan, Yide;
Liang, Jiaqi;
Zhao, Yuyang;
Li, Yuan;
Fan, Jiali;
Xue, Jiahong;
Zheng, Qiangsun;
Sun, Jiacheng

Publication type:

Article

A lump on my arm: A rare complication of radial artery catheterisation.

Published in:

2022

By:

Campbell, Saskia;
Peckler, Brad

Publication type:

Case Study

Avoiding anchoring bias by moving beyond 'mechanical falls' in geriatric emergency medicine.

Published in:

Emergency Medicine Australasia, 2018, v. 30, n. 6, p. 843, doi. 10.1111/1742-6723.13129

By:

Nagaraj, Guruprasad;
Hullick, Carolyn;
Arendts, Glenn;
Burkett, Ellen;
Hill, Keith D;
Carpenter, Christopher R

Publication type:

Article

Pulmonary haemorrhage from therapeutic rivaroxaban use: Chest radiograph consolidation is not always infection!

Published in:

Emergency Medicine Australasia, 2014, v. 26, n. 3, p. 318, doi. 10.1111/1742-6723.12235

By:

Wong, Anselm;
Koutsogiannis, Zeff;
Greene, Shaun L

Publication type:

Article

Risk of bleeding in cirrhotic patients treated with rivaroxaban.

Published in:

Liver International, 2017, v. 37, n. 10, p. 1575, doi. 10.1111/liv.13543

By:

De Gottardi, Andrea;
Garcia ‐ Pagan, Juan Carlos

Publication type:

Article

Rivaroxaban recanalized occlusive superior mesenteric vein thrombosis, but increased the risk of bleeding in a cirrhotic patient.

Published in:

Liver International, 2017, v. 37, n. 10, p. 1574, doi. 10.1111/liv.13511

By:

Qi, Xingshun;
Yoshida, Eric M.;
Mendez ‐ Sanchez, Nahum;
Guo, Xiaozhong

Publication type:

Article

The anticoagulant efficacy of rivaroxaban may be attenuated in cirrhotic patients.

Published in:

Liver International, 2017, v. 37, n. 8, p. 1252, doi. 10.1111/liv.13420

By:

De Gottardi, Andrea;
Garcia ‐ Pagan, Juan Carlos

Publication type:

Article

Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban.

Published in:

Liver International, 2017, v. 37, n. 8, p. 1251, doi. 10.1111/liv.13406

By:

Ponziani, Francesca Romana;
De Candia, Erica;
De Cristofaro, Raimondo;
Pompili, Maurizio

Publication type:

Article

Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.

Published in:

Liver International, 2017, v. 37, n. 5, p. 694, doi. 10.1111/liv.13285

By:

De Gottardi, Andrea;
Trebicka, Jonel;
Klinger, Christoph;
Plessier, Aurélie;
Seijo, Susana;
Terziroli, Benedetta;
Magenta, Lorenzo;
Semela, David;
Buscarini, Elisabetta;
Langlet, Philippe;
Görtzen, Jan;
Puente, Angela;
Müllhaupt, Beat;
Navascuès, Carmen;
Nery, Filipe;
Deltenre, Pierre;
Turon, Fanny;
Engelmann, Cornelius;
Arya, Rupen;
Caca, Karel

Publication type:

Article

Use of SSRIs with anticoagulants can increase risk of bleeding.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 10, p. 7, doi. 10.1002/pu.31218
Publication type:: Article

Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases.

Published in:

Clinical Rheumatology, 2016, v. 35, n. 3, p. 801, doi. 10.1007/s10067-015-3030-y

By:

Signorelli, Flavio;
Nogueira, Felipe;
Domingues, Vinicius;
Mariz, Henrique;
Levy, Roger

Publication type:

Article

Studies towards the Synthesis of Alkyl N-(4-Nitrophenyl)-3/2-oxomorpholine-2/3-carboxylates.

Published in:

Helvetica Chimica Acta, 2013, v. 96, n. 11, p. 2160, doi. 10.1002/hlca.201300085

By:

Trstenjak, Uroš;
Ilaš, Janez;
Kikelj, Danijel

Publication type:

Article

Mechanical Prosthetic Heart Valve Thrombosis in a Patient Receiving Rivaroxaban.

Published in:

Cardiology, 2019, v. 143, n. 3/4, p. 116, doi. 10.1159/000501361

By:

Carvalho Silva, Daniela Marisa;
Braga, Ana;
de Jesus, Ilídio;
Neves, José

Publication type:

Article

Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: Practical Considerations on the Choice of Agent and Dosing.

Published in:

Cardiology, 2018, v. 140, n. 2, p. 126, doi. 10.1159/000489922

By:

Farmakis, Dimitrios;
Davlouros, Periklis;
Giamouzis, Gregory;
Giannakoulas, George;
Pipilis, Athanasios;
Tsivgoulis, Georgios;
Parissis, John

Publication type:

Article

Practical Considerations for the Nonvitamin K Antagonist Oral Anticoagulants.

Published in:

Cardiology, 2017, v. 136, n. 2, p. 115, doi. 10.1159/000447530

By:

Trikha, Rahul;
Kowey, Peter R.

Publication type:

Article

Effects of rivaroxaban and apixaban on intimal hyperplasia in rabbits.

Published in:

Turkish Journal of Vascular Surgery (TJVS), 2022, v. 31, n. 3, p. 148, doi. 10.9739/tjvs.2022.09.03

By:

Kemahli, Mustafa Baris;
Gencpinar, Tugra;
Dursun, Huseyin;
Bilen, Cagatay;
Akokay, Pinar;
Bayrak, Serdar;
Erdal, Abidin Cenk

Publication type:

Article

Effects of rivaroxaban on myocardial ischemia-reperfusion injury in rats.

Published in:

Medicine Science, 2022, v. 11, n. 4, p. 1456, doi. 10.5455/medscience.2022.07.166

By:

Kahraman, Ercan;
Akca, Baris;
Colak, Mehmet Cengiz;
Disli, Olcay Murat;
Parlakpinar, Hakan;
Battaloglu, Bektas;
Erdil, Nevzat

Publication type:

Article

Evaluation of cerebral microbleeds in patients using rivaroxaban for cardioembolism prophylaxis in non-valvular atrial fibrillation.

Published in:

Medicine Science, 2021, v. 10, n. 4, p. 1097, doi. 10.5455/medscience.2021.02.052

By:

Sahin, Sukru;
Baykan, Ali Haydar;
Abidin Tak, Ali Zeynel

Publication type:

Article

Development and validation of stability-indicating RP-HPLC method for rivaroxaban in tablet dosage form.

Published in:

Journal of Research in Pharmacy, 2022, v. 26, n. 6, p. 1703, doi. 10.29228/jrp.261

By:

NIMJE, Hemlata;
CHAVAN, Rajashree;
PAWAR, Smita;
DEODHAR, Meenakshi

Publication type:

Article

Naczyniowa dawka rywaroksabanu -- wciąż zbyt rzadko stosowana.

Published in:

Folia Cardiologica, 2025, v. 19, p. 1, doi. 10.5603/fc.99672

By:

Domański-Giec, Ireneusz;
Wożakowska-Kapłon, Beata

Publication type:

Article

Progress in the treatment of cardiovascular diseases News from the American Heart Association Scientific Sessions 2020.

Published in:

Folia Cardiologica, 2021, v. 16, n. 3, p. 209, doi. 10.5603/FC.2021.0018

By:

Ojrzanowski, Marcin;
Kasprzak, Jarosław D.

Publication type:

Article

Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China.

Published in:

JAMA Network Open, 2021, v. 4, n. 7, p. e2118816, doi. 10.1001/jamanetworkopen.2021.18816

By:

Gu, Hong-Qiu;
Yang, Xin;
Wang, Chun-Juan;
Zhao, Xing-Quan;
Wang, Yi-Long;
Liu, Li-Ping;
Meng, Xia;
Jiang, Yong;
Li, Hao;
Liu, Chelsea;
Xiong, Yun-Yun;
Fonarow, Gregg C.;
Wang, David;
Xian, Ying;
Li, Zi-Xiao;
Wang, Yong-Jun

Publication type:

Article

Comparison Between Non–vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.

Published in:

JAMA Network Open, 2021, v. 4, n. 2, p. e2036304, doi. 10.1001/jamanetworkopen.2020.36304

By:

Chen, Dong-Yi;
Tseng, Chi-Nan;
Hsieh, Ming-Jer;
Lan, Wen-Ching;
Chuang, Cheng-Keng;
Pang, See-Tong;
Chen, Shao-Wei;
Chen, Tien-Hsing;
Chang, Shang-Hung;
Hsieh, I-Chang;
Chu, Pao-Hsien;
Wen, Ming-Shien;
Chen, Jen-Shi;
Chang, John Wen-Cheng;
See, Lai-Chu;
Huang, Wen-Kuan

Publication type:

Article

Serious bleeding in patients with atrial fibrillation using diltiazem with apixaban or rivaroxaban.

Published in:

Cardiology Research Review, 2024, n. 113, p. 4

By:

Sasse, Alexander

Publication type:

Article

Rivaroxaban in rheumatic heart disease-associated atrial fibrillation.

Published in:

Cardiology Research Review, 2022, n. 102, p. 3

By:

Sasse, Alexander

Publication type:

Article

Rivaroxaban monotherapy vs combination therapy with antiplatelets on total thrombotic and bleeding events in atrial fibrillation with stable coronary artery disease.

Published in:

Cardiology Research Review, 2022, n. 101, p. 6

By:

R., Naito

Publication type:

Article

The Efficacy of Andexanet Alfa for the Reversal of Factor Xa Inhibitors Is Not Influenced by Hemodilution with Different Volume Expanders.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 22, p. 6706, doi. 10.3390/jcm13226706

By:

Wienhold, Jan;
Rossaint, Rolf;
Vandeput, Eline;
Grottke, Oliver

Publication type:

Article

The Net Clinical Outcome of Dual-Pathway Inhibition in Clinical Practice: The "Xarelto plus Acetylsalicylic Acid: Treatment Patterns and Outcomes in Patients with Atherosclerosis" Registry.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 1956, doi. 10.3390/jcm13071956

By:

Breitenstein, Alexander;
Gay, Alain;
Vogtländer, Kai;
Fox, Keith A. A.;
Steffel, Jan

Publication type:

Article

Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 4, p. 1073, doi. 10.3390/jcm13041073

By:

Deitelzweig, Steven;
Kang, Amiee;
Jiang, Jenny;
Gao, Chuan;
Luo, Xuemei;
Atreja, Nipun;
Han, Stella;
Cheng, Dong;
Loganathan, Saarusri R;
Lip, Gregory Y. H.

Publication type:

Article

Usefullness of Heparin Calibrated Anti-Xa Activity to Assess Anticoagulant Activity of Apixaban and Rivaroxaban in Emergency Patients Scheduled for Acute Interventions.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 21, p. 6785, doi. 10.3390/jcm12216785

By:

Riahi, Nada;
Rozen, Laurence;
Demulder, Anne

Publication type:

Article

Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 20, p. 6686, doi. 10.3390/jcm12206686

By:

Chiou, Wei-Ru;
Su, Min-I;
Lee, Ying-Hsiang;
Lin, Po-Lin;
Liu, Cheng-Wei

Publication type:

Article

Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6427, doi. 10.3390/jcm12196427

By:

Santini, Paolo;
Mosoni, Carolina;
D'Errico, Alessandro;
Porceddu, Enrica;
Lupascu, Andrea;
Valeriani, Emanuele;
Tondi, Paolo;
Pola, Roberto;
Porfidia, Angelo

Publication type:

Article

The Role of Anti-Factor Xa Activity in the Management of Ecchymosis in Patients Receiving Rivaroxaban after Total Knee Arthroplasty.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 1161, doi. 10.3390/jcm12031161

By:

Wang, Han;
Liu, Jiacheng;
Lai, Xiaofei;
Li, Xinyu;
Huang, Wei

Publication type:

Article

Reduced- or Half-Dose Rivaroxaban Following Left Atrial Appendage Closure: A Feasible Antithrombotic Therapy in Patients at High Risk of Bleeding?

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 847, doi. 10.3390/jcm12030847

By:

Zhou, Xiao-Dong;
Chen, Qin-Fen;
Lin, Fang;
Wang, Liangguo;
Chen, Yihe;
Liang, Dongjie;
Huang, Weijian;
Xiao, Fangyi

Publication type:

Article

Comparative Effectiveness of Apixaban and Rivaroxaban Lead-in Dosing in VTE Treatment: Observational Multicenter Real-World Study.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 1, p. 199, doi. 10.3390/jcm12010199

By:

Alshaya, Omar A.;
Korayem, Ghazwa B.;
Al Yami, Majed S.;
Qudayr, Asma H.;
Althewaibi, Sara;
Fetyani, Lolwa;
Alshehri, Shaden;
Alnashmi, Fai;
Albasseet, Maram;
Alshehri, Lina;
Alhushan, Lina M.;
Almohammed, Omar A.

Publication type:

Article

Comparison of the Efficacy and Safety of Rivaroxaban and Enoxaparin as Thromboprophylaxis Agents for Orthopedic Surgery—Systematic Review and Meta-Analysis.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 14, p. 4070, doi. 10.3390/jcm11144070

By:

Rinaldi, Ikhwan;
Amin, Ihya Fakhrurizal;
Shufiyani, Yuli Maulidiya;
Dewantara, Idham Rafly;
Edina, Brenda Cristie;
Winston, Kevin;
Nurrobi, Yusuf Aji Samudera

Publication type:

Article

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 8, p. 2236, doi. 10.3390/jcm11082236

By:

Jakimczuk, Aleksandra;
Kalaska, Bartlomiej;
Kamiński, Kamil;
Miklosz, Joanna;
Yusa, Shin-Ichi;
Pawlak, Dariusz;
Szczubiałka, Krzysztof;
Mogielnicki, Andrzej

Publication type:

Article

Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro ® Clotting Time: An Ex Vivo Spiking Study in A Cohort of Trauma Patients.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3476, doi. 10.3390/jcm10163476

By:

Oberladstätter, Daniel;
Schlimp, Christoph J.;
Zipperle, Johannes;
Osuchowski, Marcin F.;
Voelckel, Wolfgang;
Grottke, Oliver;
Schöchl, Herbert

Publication type:

Article

Delayed Thrombin Generation Is Associated with Minor Bleedings in Venous Thromboembolism Patients on Rivaroxaban: Usefulness of Calibrated Automated Thrombography.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 7, p. 2018, doi. 10.3390/jcm9072018

By:

Zalewski, Jaroslaw;
Stepien, Konrad;
Nowak, Karol;
Caus, Sandi;
Butenas, Saulius;
Undas, Anetta

Publication type:

Article

Rivaroxaban Effects Illustrate the Underestimated Importance of Activated Platelets in Thrombin Generation Assessed by Calibrated Automated Thrombography.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 11, p. 1990, doi. 10.3390/jcm8111990

By:

Makhoul, Stephanie;
Panova-Noeva, Marina;
Regnault, Véronique;
Ruf, Wolfram;
Wenzel, Philip;
Lagrange, Jeremy

Publication type:

Article

Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review.

Published in:

Archives of Rheumatology, 2020, v. 35, n. 1, p. 107, doi. 10.5606/ArchRheumatol.2020.7375

By:

KHODASHAHI, Mandana;
REZAIEYAZDI, Zahra;
SAHEBARI, Maryam

Publication type:

Article

Effects of anticoagulant drugs on wound healing process in a rat model: a comparative study.

Published in:

Journal of Wound Care, 2020, v. 29, n. 1, p. 44, doi. 10.12968/jowc.2020.29.1.44

By:

Çevirme, Deniz;
Savluk, Ömer Faruk;
Başaran, Eylül Kafalı;
Aksoy, Rezzan;
Elibol, Ahmet;
Baş, Tolga;
Keser, Sevinç;
Adademir, Taylan;
Yılmaz, Bayram

Publication type:

Article

Verification of rivaroxaban quantification by the Innovance Anti-Xa from an in-house assay.

Published in:

New Zealand Journal of Medical Laboratory Science, 2024, v. 78, n. 2, p. 103

By:

Su, Brandon

Publication type:

Article

Validation of DOAC-Stop for the elimination of direct oral anticoagulants in plasma.

Published in:

New Zealand Journal of Medical Laboratory Science, 2024, v. 78, n. 2, p. 98

By:

Bell, Eva;
Thalari, Gabriel

Publication type:

Article

Effects of Rivaroxaban on Coagulation Assays in Patients with Small Pulmonary Embolism and Deep Vein Thrombosis in Relation to Body Mass Index.

Published in:

Journal of Cardio-Thoracic Medicine, 2019, v. 7, n. 3, p. 491

By:

Ghahremani, Shima;
Asaei, Esmat;
Shabestari, Mahmoud Mohammadzadeh;
Jalalyazdi, Majid

Publication type:

Article

Pharmacogenetic Approach for the Prevention of Rivaroxaban's ADRs: A Systematic Review and Meta-Analysis.

Published in:

Genetics Research, 2023, v. 2023, p. 1, doi. 10.1155/2023/6105320

By:

Mardi, Parham;
Abbasi, Bahareh;
Shafiee, Arman;
Afsharmoghaddam, Tara

Publication type:

Article

Surgical Management of Complex Ankle Bony Impingement Combined With Chronic Ankle Instability.

Published in:

Orthopaedic Journal of Sports Medicine, 2024, v. 12, n. 10, p. 1, doi. 10.1177/23259671241270309

By:

Bai, Lu;
Liu, Sanbiao;
Tang, Lubo;
Guan, Siyao;
Xie, Xiaoxiao;
Zhang, Xintao

Publication type:

Article

Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching study.

Published in:

BMC Pharmacology & Toxicology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s40360-023-00712-8

By:

Ramos-Isaza, Estefan;
Tuta-Quintero, Eduardo;
Bastidas-Goyes, Alirio;
Diaz-Quijano, Diana;
Aponte-Murcia, Carolina;
Espitia-Angel, Julian;
Pinto-Beltran, Daniel;
Rincón-Hernández, Johan;
Sánchez-Cuellar, Juan;
Pérez-Bueno, Jesus;
Giraldo-Cadavid, Luis F.

Publication type:

Article

Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin and Aspirin for Stroke Prevention Atrial Fibrillation (SPAF) in the Indonesian healthcare setting.

Published in:

Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia, 2019, v. 30, n. 1, p. 74, doi. 10.14499/indonesianjpharm30iss1pp74

By:

Iwan Dwiprahasto;
Erna Kristin;
Dwi Endarti;
Rizaldy Taslim Pinzon;
Alfi Yasmina;
Jarir At Thobari;
Woro Rukmi Pratiwi;
Yolanda Dyah Kartika;
Christiana Trijayanti

Publication type:

Article

Bioequivalence and Food Effect Assessment Between 2 Oral Tablet Formulations of Rivaroxaban 20 mg in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 5, p. 391, doi. 10.1002/cpdd.1511

By:

Tang, Kaixian;
Chen, Yingrong;
Mei, Jue;
Bo, Hui;
Liu, Qing;
Wang, Wei;
Xu, Min;
Jin, Qiuyue;
Yang, Shuixin

Publication type:

Article